Osiris Therapeutics Report issue

For profit Phase 2 Phase 3
Founded: Columbia MD United States (1992)
Status: Acquired by Smith & Nephew (2019)

Organization Overview

First Clinical Trial
2005
NCT00136903
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Osiris Therapeutics | Osiris Therapeutics, Inc.